Abstract
One of the most common nail pathologies is onychomycosis, a fungal nail infection. The low efficiency of existing methods for the treatment of onychomycosis stimulates the search for new drugs and technologies for their delivery under the nail plate. The aim of the investigation was to study the possibility of using Er:YLF laser radiation for sequential laser microporation of the human nail plate and active laser delivery of modern photodynamic preparations and zinc-containing nanomaterials under the nail plate, as well as to determine their antimycotic activity against the Candida albicans fungus under photodynamic exposure with a wavelength of 656±10 nm. A 0.001 % aqueous solution of methylene blue, a chlorine-containing Revixan gel, as well as zinc-containing nanomaterials, which are aqueous solutions of polyvinylpyrrolidone gel with different concentrations of Zn(NO3)2 nanoparticles and acidity, were studied. It was established that the smallest number of laser pulses required for in vitro microporation of the nail plate and active laser delivery under the nail plate is required when using a 0.001 % aqueous solution of methylene blue, and the largest is required when using Revixan gel. For zinc-containing nanomaterials, an increase in the concentration of Zn(NO3)2 nanoparticles from 14 to 40 % leads to an increase in the number of laser pulses required for active drug delivery under the nail plate by 1.25 times, while a change in the acidity of the pH gel from 7.0 to 6.7 does not has a significant impact on it. It was found that all the studied drugs in combination with photodynamic action at a wavelength of 656±10 nm have an antimycotic effect on the Candida albicans fungus culture. The minimum growth rate of Candida albicans colonies was observed when using the Revixan gel, for which the antimycotic activity reached 73.8 %. The obtained results can be applied in the development of laser systems and technologies for the treatment of fungal diseases, including for photodynamic therapy of onychomycosis.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.